Who can administer
INFUSION may be administered by registered competent doctor or nurse/midwife.
Bolus injection- Restricted see appendix 1
Important information
- Always prescribe the dose in micrograms
- For dose guidance for transferring patients from PO to IV therapy- see under 'Dose'
- See monitoring requirements
- Renal dose adjustments are required
Available preparations
Lanoxin 500 microgram per 2ml ampoule
Reconstitution
Already in solution
Draw up using a 5micron filter needle
Dilute further prior to administration
Infusion fluids
Sodium chloride 0.9% or Glucose 5%
Methods of intravenous administration
Intermittent intravenous infusion (using an electronically controlled infusion device) (preferred route)
- Add required dose to 100ml of infusion fluid. (ref 1)
- A 50ml infusion may be used if required (eg fluid restriction) but the residual volume in the infusion line must be flushed through at the same rate to avoid significant underdosing
- If loading with repeated fractions of small doses (e.g. 50%, 25%, 25%) the infusion may be given over 10 to 20 minutes.
- However, where large loading doses are required in emergencies (e.g. 750microgram to 1000microgram) a minimum infusion time of 2 hours is suggested (ref 1)
- If using a two hour infusion time, protect infusion solution from light
Slow intravenous injection (not generally recommended)
- Intravenous infusion is preferred but if essential digoxin may be administered by slow intravenous injection as follows:
- Bolus administration is more likely to cause adverse effects. Patients should be monitored closely for signs of digoxin toxicity; hypertension and reduced coronary flow (ref 1)
- Either dilute at least four fold (add 4ml to 1ml) with either Sodium chloride 0.9% or Glucose 5% and administer over 10 to 20 minutes(ref 1,3) OR
- If fluid-restricted: administer undiluted via a large vein or central line over at least 5 minutes (ref 3) (unlicensed)
Dose in adults
LOADING DOSE (for patients who have not been given cardiac glycosides within the previous two weeks)
- The normal loading dose is 500 to 1000 microgram (depending on age, lean body weight and renal function)
- This is usually given in three divided doses of 50%, 25%, 25%
- Each part of the dose should be given four to eight hours after the last
- Example: total dose required is 1000microgram:
- Give 500micogram
- Followed by 250microgram four hours later
- Followed by a further 250microgram after a further four hours
- An assessment of clinical response should be performed before giving each additional dose
Urgent (emergency) loading required (ref 2)
- Give 750 to 1000 microgram over a minimum of 2 hours
- A reduced loading dose may be needed if the patient has received digoxin in the last 2 weeks
MAINTENANCE DOSE
- Where a patient is on oral digoxin, and a temporary switch to IV is indicated eg if a patient is unable to take oral digoxin, the intravenous dosage should be reduced by approximately 33% - for example, 250 micrograms tablet is approximately equivalent to 166 micrograms IV - round to 175 micrograms
- Monitor levels closely if switching between routes of administration
Renal impairment
Dose reductions required - contact pharmacy for advice
Monitoring
Telemetry monitoring during administration (ref 5)
Monitoring of levels
- At least 6 or more hours after the last dose to allow for redistribution
Therapeutic range
- Heart failure: Trough levels usually between 0.64 to 1.28 nanomols/L (0.5 to 1nanograms/ml)
- Other indications: Trough levels usually between 0.64 and 2.6 nanomol/L (0.5 to 2 nanograms/ml) (ref 4)
- However, toxicity may occur with lower digoxin serum concentrations. In deciding whether a patient's symptoms are due to digoxin, the clinical state together with the serum potassium level and thyroid function are important factors.
Further information
- Intramuscular injection is NOT RECOMMENDED, as it is painful and is associated with muscle necrosis
- An antidote (Digifab) is available for suspected digoxin toxicity
Storage
References
SPC March 2020
1. Medusa Injectable Medicines Guide downloaded 03/2022
2: BNF 83
3: Minimum Infusion Volumes for Fluid Restricted Critically Ill Patients 4rd Ed
4. Medicines Complete - assessed online 03/2022
5: Local guidelines, email on file, January 2017
Therapeutic classification
Cardiac glycosides